C R Bard Inc $150.25

down -2.88


29/7/2014 04:00 PM  |  NYSE : BCR  
Industries : Health Services / Medical Instruments & Supplies
Get Trend Analysis Icon Get BCR Trend Analysis - it has outperformed the S&P 500 by 17%

Partner Headlines

  1. Earnings Scheduled For July 24, 2014

    Benzinga
  2. UPDATE: S&P Capital Downgrades C.R. Bard On Revised 2014 EPS Estimate

    Benzinga
  3. Headwinds For C.R. Bard, According To Barclays

    Benzinga
  4. Benzinga's Top Downgrades

    Benzinga
  5. Morgan Stanley Remains Concerned About C.R. Bard

    Benzinga
  6. Stocks To Watch For June 12, 2014

    Benzinga
  7. Becton, Dickinson and Co. (BDX) Dividend Stock Analysis

    GuruFocus
  8. Morgan Stanley Still Sees Acceleration Risk for C.R. Bard

    Benzinga
  9. Earnings Scheduled For April 22, 2014

    Benzinga
  10. UPDATE: Bank of America Downgrades C.R. Bard on Multiple Factors

    Benzinga
  11. Yacktman Funds Comments on C.R. Bard Inc.

    GuruFocus
  12. Bard Announces $500M Share Repurchase Authorization

    Benzinga
  13. Yacktman Fund Comments on C.R. Bard Inc.

    GuruFocus
  14. Earnings Scheduled For January 30, 2014

    Benzinga
  15. Risk and Cycles: Looking at Buybacks, Debt, Cash

    YCharts
  16. Weekly Insider Sells Highlight: BCR, GLUU, AMT, APOL, JACK

    GuruFocus
  17. Anti-Elitism: Beating The Dividend Aristocrats

    YCharts
  18. UPDATE: Goldman Sachs Upgrades C.R. Bard as Elements Driving Sell Thesis ...

    Benzinga
  19. UPDATE: Piper Jaffray Upgrades C.R. Bard on Improving Organic Growth Profile, ...

    Benzinga
  20. Benzinga's Top Upgrades

    Benzinga
  21. C.R. Bard Rises After Q3 Earnings Beat (BCR)

    Benzinga
  22. Earnings Scheduled For October 22, 2013

    Benzinga
  23. UPDATE: Citigroup Raises PT on C.R. Bard on Adjusted BCR Estimates

    Benzinga
  24. CryoLife Says Will Receive ~$15.1M Related to Purchase of Medafor by CR ...

    Benzinga
  25. Market Wrap For Wednesday, September 4: Markets Increase Slightly As M&As ...

    Benzinga
  26. Benzinga's M&A Chatter for Wednesday September 4, 2013

    Benzinga
  27. Morning Market Movers

    Benzinga
  28. Benzinga's Top Pre-Market Gainers

    Benzinga
  29. UPDATE: Bard to Purchase Rochester Medical at $20/Share, or ~$262M Deal

    Benzinga
  30. UPDATE: Bank of America Raises PT on C.R. Bard Following CEO/CFO Meetings

    Benzinga
  31. St. Jude acquires new tech

    IBD
  32. St. Jude, C.R. Bard Make Medical Device Acquisitions

    IBD
  33. CR Bard Announces Deal to Buy Medafor for $200M; Sees Deal Dilutive to ...

    Benzinga
  34. UPDATE: Citigroup Reiterates Neutral Rating, Lowers PT on C.R. Bard

    Benzinga
  35. UPDATE: BMO Capital Markets Reiterates Market Perform Rating, Lowers PT ...

    Benzinga
  36. UPDATE: C.R. Bard Q4 Profit Rises 13%

    Benzinga
  37. UPDATE: Morgan Stanley Downgrades C.R. Bard to Underweight on Lagging Organic ...

    Benzinga
  38. Donald Yacktman Finds Two Undervalued Companies in His Most Bought, In-Favor ...

    GuruFocus
  39. Medical Device Makers: Repeal the New Tax!

    FoxBusiness
  40. Benzinga's Top Initiations

    Benzinga
  41. Steven Cohen's SAC Capital Advisors Q3 Updates: Buys Fossil, Fastenal Company ...

    GuruFocus
  42. C.R. Bard Inc. Reports Operating Results (10-Q)

    GuruFocus
  43. Bard Acquires Neomend For $140M

    Benzinga
  44. Earnings Scheduled For October 23, 2012

    Benzinga
  45. Yacktman at Texas Lutheran - Notes

    GuruFocus
  46. Medtronic Inc. (MDT) Dividend Stock Analysis

    GuruFocus
  47. UPDATE: Bank of America Merrill Lynch Reiterates Neutral Rating, Raises ...

    Benzinga
  48. C.R. Bard Inc. (BCR) Chairman and CEO Timothy M Ring sells 21,923 Shares

    GuruFocus
  49. C.R. Bard Inc. (BCR) President and COO John H Weiland sells 15,554 Shares

    GuruFocus
  50. C.R. Bard Inc. Reports Operating Results (10-Q)

    GuruFocus
Trading Center